Coronavirus deaths twice in Asians and Blacks reports UK

▴ Coronavirus deaths twice in Asians and Blacks reports UK
UK survey shows BAME (Black Asian and Ethnic Minority) are at double the risk from COVID-19

Black, Asian, and Ethnic Minority (BAME) people are up to twice as likely to die of coronavirus in the UK than white British people are, a review has concluded.

The Public Health England review into disparities around the risk of coronavirus identified age as the biggest factor, as has been widely acknowledged, but Matt Hancock said being BAME is a "major risk factor".People of Bangladeshi ethnicity are around twice as likely to die of coronavirus compared to people of White British ethnicity.

People of Chinese, Indian, Pakistani, Other Asian, Caribbean, and Other Black ethnicity are between 10% and 50% more likely to die when compared with White people. The health secretary, updating MPs on the review's findings, said it is "very clear" that some people are "significantly more vulnerable" than others.

Black men, for example, are at least three times more likely to catch Covid-19 than white men are. The highest diagnosis rates were in black people, with 436 in females and 649 in males per 100,000. The lowest was in white people, at 220 in females and 224 in males, per 100,000.

Death rates in the most deprived areas are "more than double" those in the least deprived areas, the review also revealed.The review said "the impact of COVID-19 has replicated existing health inequalities and, in some cases, has increased them".Labour shadow health secretary Jon Ashworth said the figures show Covid-19 “thrives on inequalities”.He told MPs: "Yes indeed, black lives matter but it is surely a call to action that black, Asian and minority ethnic people are more likely to die from Covid and more likely to be admitted to intensive care from Covid.”

Tower Hamlets has one of the largest ethnic minority populations in the UK, including the largest British Bangladeshi community meaning that many families have been badly affected by this virus.

Labour MP for Bethnal Green and Bow, Rushanara Ali told ITV News: "It's very important that the government takes into account the different impacts on different groups, without doing that there is a real risk that we are going to have more deaths in these groups, who are already being hit very hard."

She added: "The first step is for the government to take heed of the evidence and follow the science."

"The prime minister and others keep saying they are following the science, what we've seen in recent weeks is that actually they put politics over science and that is dangerous and that is costing lives," she added.

The relationship between ethnicity and health is "complex" and likely to be the result of a "combination of factors", the review said.The review said people of BAME communities are likely to be at increased risk of acquiring the infection because they are more likely to live in urban areas, in overcrowded households, in deprived areas, and have jobs that expose them to higher risk.

BAME people are more likely to face "poorer outcomes" after catching the virus, the report said, because some health conditions are more common among certain ethnic groups. For example, people of Bangladeshi and Pakistani backgrounds have higher rates of cardiovascular disease than people of White British people.

The review also showed that among those diagnosed with Covid-19, people who were 80 or older were 70 times more likely to die than those under 40. It said working-age men (aged 20-64) with confirmed coronavirus were twice as likely to die as women. There's also a significant relationship between coronavirus deaths and diabetes.

A huge 21% of death certificates mentioning Covid-19 also mentioned diabetes. Zubaida Haque, Interim Director of Runnymede Trust, described the lack of government recommendations on the findings as "wholly disappointing".

She told ITV News: "It’s wholly disappointing and dissatisfying to find the Government has not only not addressed the causes for why BAME people are disproportionately dying, but that there’s not a single recommendation."

"What does it mean? What is the point of having a review that asks the question of why is it that BAME people are disproportionately dying from Covid but then doesn’t have a single answer?"

"This is a question of life and death and what it makes us realize is that this Government doesn’t think it’s important," she added.

Story Source; itv.com

Tags : #BAME #UK #COVID-19 #DeathRate

About the Author


Team Medicircle

Related Stories

02 Apr

DCDC’s $150 Crore Expansion: Can Innovative Clinics End India's Kidney Crisis?

As the healthcare landscape evolves, initiatives like these will determine the future of medical care in the country.

View
01 Mar

India’s Pharma Revolution: Can New Regulatory Reforms Unleash a $42 Billion Industry?

The potential rewards are enormous a robust, efficient, and competitive pharmaceutical industry that not only fuels domestic growth but also serves as a reliable supplier of essential medicines to the world.

View
27 Feb

India’s Newborns Are Dying from Sepsis And No One Is Talking About It

Newborn sepsis is a complex problem that requires innovative solutions. More funding for research on rapid diagnostic tests, alternative treatments is essential to tackle this growing crisis.

View
26 Feb

The Corporate Invasion of Indian Hospitals: What It Means for You

The question remains: will India’s hospital sector continue on its current trajectory and become a global leader in healthcare, or will the challenges of cost, infrastructure, and regulatory hurdles slow down this remarkable journey.

View
24 Feb

The Great Indian Medical Education Paradox: More Seats, Fewer Students, Collapsing System

The NMC’s strategy to allow non-medical faculty and offer incentives for non-clinical PG courses may help in the short term, but a broader shift in how medical education is structured is necessary.

View
24 Feb

The Dark Side of India’s Pharma Boom: How Banned Drugs Found a New Market in West Africa

Stricter regulations, greater transparency, and proactive enforcement are the only ways to ensure that India’s “pharmacy of the world” reputation is built on trust and safety, not on scandals and cover-ups.

View
21 Feb

India vs. Trump’s Pharma Tariff: The Battle Over Affordable Medicine

Indian pharmaceutical companies may suffer short-term financial setbacks, but they hold the upper hand, because the U.S. needs Indian generics more than India needs the U.S. market.

View
19 Feb

Tata’s ₹500-Crore Gamble: Is Healthcare the New Playground for India’s Corporate Giants?

As India’s healthcare sector continues to evolve, corporate giants like Tata are not just participants but key drivers of change.

View
19 Feb

Public Hospitals Go High-Tech: AIIMS Delhi Leads India’s Robotic Surgery Wave

AIIMS sets a precedent for other hospitals across India to follow. If robotic surgery becomes more widespread, the dream of world-class healthcare for all Indians may not be as distant as it once seemed.

View
12 Feb

First in India: Dr. Anshumala Shukla-Kulkarni Becomes Asia’s First Certified Endometriosis Specialist

Delayed diagnosis remains one of the biggest challenges. More awareness campaigns, educational programs, and inclusion of endometriosis can help detect the condition early and improve treatment outcomes.

View

-Advertisements-




Trending Now

From Scroll to Squint: How Reels Are Reshaping Your VisionApril 02, 2025
Moscow Center for Diagnostics and Telemedicine Receives License for Radiology Residency ProgramApril 02, 2025
CARE Hospitals Launches AI-Powered Non-Invasive Therapy – An innovative modality introduced in Telangana & Andhra PradeshApril 02, 2025
High-Rise Heart Attacks: Are Skyscrapers Turning Survival into a Race Against Time?April 02, 2025
DCDC’s $150 Crore Expansion: Can Innovative Clinics End India's Kidney Crisis?April 02, 2025
Medanta Rolls Out ‘Colon Tunnel on Wheels’ to Drive Awareness on Colorectal Cancer Prevention & Early DetectionApril 01, 2025
Zigly launches 2 pet hospitals, opens 4 new stores; expects ARR to more than double in 1-2 yearsApril 01, 2025
University of Leeds Announces International Masters Regional Scholarships for 2025April 01, 2025
Avantor Recognized with Two Prestigious Awards at Asia-Pacific Biopharma Excellence Awards 2025April 01, 2025
Foundation Stone Laid for Madhav Netralaya Eye Hospital & Research CentreApril 01, 2025
Doomscrolling at Midnight: How Indians Are Sacrificing Sleep for ScreensMarch 31, 2025
Essential Medicines Price Surge: Are Patients Paying the Price?March 31, 2025
Prioritize your health during the holy days of RamzanMarch 31, 2025
Tired of Stomach Cramps? These Simple Foods Can Heal Your GutMarch 31, 2025
Regional growth booming for startups in 2024 - QBO Innovation studyMarch 31, 2025
Is long-acting HIV treatment as good as taking daily pills?March 31, 2025
Right to safe abortion cannot be dislocated from human rightsMarch 28, 2025
Popeyes® Opens Third Store in Hyderabad at Inorbit MallMarch 28, 2025
Popeyes® Opens Third Store in Hyderabad at Inorbit MallMarch 28, 2025
10 New HIV Cases in 2 Months: Has Kerala’s Drug Problem Gone Too Far?March 28, 2025